- Company Overview for ASKA PHARMACEUTICAL CO., LTD (FC038710)
- Filing history for ASKA PHARMACEUTICAL CO., LTD (FC038710)
- People for ASKA PHARMACEUTICAL CO., LTD (FC038710)
- UK establishments for ASKA PHARMACEUTICAL CO., LTD (FC038710)
- More for ASKA PHARMACEUTICAL CO., LTD (FC038710)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
11 Dec 2023 | OSTM03 | Termination of appointment for a UK establishment - Transaction OSTM03- BR023805 Person Authorised to Represent terminated 01/06/2023 naoaki shibata | |
29 Nov 2023 | AA | Full accounts made up to 31 March 2023 | |
25 Oct 2023 | OSTM03 | Termination of appointment for a UK establishment - Transaction OSTM03- BR023805 Person Authorised to Accept terminated 01/06/2023 naoaki shibata | |
29 Sep 2023 | OSAP05 | Appointment of Masanori Nobata as a person authorised to represent UK establishment BR023805 on 1 June 2023. | |
30 Aug 2023 | AA | Full accounts made up to 31 March 2022 | |
01 Feb 2023 | OSCH03 | Director's details changed for Souta Yamaguchi on 21 November 2022 | |
05 Dec 2022 | OSAP01 | Appointment of Maiko Mori as a director on 28 June 2022 | |
05 Dec 2022 | OSCH03 | Director's details changed for Souta Yamaguchi on 21 November 2022 | |
05 Dec 2022 | OSTM01 | Termination of appointment of Kazuhiko Kato as a director on 28 June 2022 | |
04 Aug 2021 | OS-PAR |
Appointment at registration for BR023805 - person authorised to represent, Shibata Naoaki One Lyric Square 1 Lyric Square London United Kingdomw6 0Nb
|
|
04 Aug 2021 | OSIN01 | Registration of a UK establishment of an overseas company |